Advanced Search

Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2015 June;106(3) > Minerva Medica 2015 June;106(3):169-75

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA MEDICA

A Journal on Internal Medicine

Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236

Frequency: Bi-Monthly

ISSN 0026-4806

Online ISSN 1827-1669

 

Minerva Medica 2015 June;106(3):169-75

    REVIEWS

An update on the use of melatonin as a stroke therapeutic

Gonzales-Portillo G. S., Lozano D., Aguirre D., Reyes S., Borlongan C. V., Tajiri N., Kaneko Y.

Department of Neurosurgery and Brain Repair, Center of Excellence for Aging and Brain Repair, University of South Florida College of Medicine, Tampa, FL, USA

Delivery of melatonin and targeting melatonin receptors pose as neuroprotective strategies for stroke therapy. The potential of melatonin-based therapeutics for clinical application in stroke patients requires translational research to guide the conduct of clinical trials. We review recent preclinical and clinical data that support the use of melatonin for stroke.

language: English


FULL TEXT  REPRINTS

top of page